The Law Offices of Frank R. Cruz Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of InvestorsBusiness Wire • 09/10/24
The Schall Law Firm Urges Public Participation In A Case For Securities Fraud Against Sage Therapeutics IncAccesswire • 09/10/24
Churchill Stateside Group Closes $47.7MM in Financing for the New Construction of a 144-Unit Apartment Community in Lake Charles, LouisianaBusiness Wire • 09/10/24
BLS International Implements Robust Measures to Ensure Fair and Transparent Visa Appointment Process in MoroccoBusiness Wire • 09/10/24
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreAccesswire • 09/09/24
Sage Therapeutics Inc. May Have Violated Securities Law Violations And Investors Are Encouraged To Contribute To A LawsuitAccesswire • 09/09/24
SAGE INVESTOR ALERT: Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAccesswire • 09/09/24
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class Action Contact Levi & Korsinsky to Learn MoreAccesswire • 09/08/24
The Schall Law Firm Invites Sage Therapeutics Inc Shareholders To Partake In A Case For FraudAccesswire • 09/08/24
SAGE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead CaseGlobeNewsWire • 09/07/24
A Securities Fraud Lawsuit Has Been Filed Against Sage Therapeutics, Inc. And Investors Are Urged To Contact The Schall Law FirmAccesswire • 09/06/24
Sage Therapeutics Inc Is Being Sued For Committing Securities Law Violations And The Schall Law Firm Encourages Shareholder ParticipationAccesswire • 09/05/24
SAGE INVESTOR ALERT: Edelson Lechtzin LLP Urges Sage Therapeutics, Inc. (NASDAQ: SAGE) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class ActionPRNewsWire • 09/05/24
SAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 09/05/24
Investors Are Invited To Join The Schall Law Firm In A Securities Fraud Case Against Sage Therapeutics, Inc.Accesswire • 09/05/24
SAGE Class Action Alert: Robbins LLP Reminds Stockholders of the Sage Therapeutics, Inc. Class ActionGlobeNewsWire • 09/04/24
Securities Fraud Charges Have Been Filed Against Sage Therapeutics Inc And The Schall Law Firm Is Looking For Shareholders Who Want RestitutionAccesswire • 09/03/24
The Schall Law Firm Encourages Public Participation In A Case Against Sage Therapeutics Inc. For Possible Securities FraudAccesswire • 09/03/24
REMINDER – Sage Therapeutics, Inc. Investor Alert: Robbins LLP Reminds Shareholders of the SAGE Class Action LawsuitBusiness Wire • 09/02/24
The Schall Law Firm Is Looking Into Whether Sage Therapeutics Inc. Violated Securities Regulations And Investors Are Urged To Reach OutAccesswire • 09/01/24
SAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • 09/01/24
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGEGlobeNewsWire • 09/01/24
Stakeholders In Sage Therapeutics Inc Are Invited To Participate With The Schall Law Firm In An Investigation Into Possible Securities FraudAccesswire • 08/31/24
SAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sage Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 08/31/24
